PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
17-Jun-2022 Formycon publishes Update on Development Projects Formycon AG
17-Jun-2022 Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission Relief Therapeutics Holding SA
16-Jun-2022 Biophytis presents preclinical efficacy data for Sarconeos (BIO101) in Spinal Muscular Atrophy (SMA), a rare neuromuscular disease Biophytis
15-Jun-2022 IGEA Pharma N.V.: IGEA to get SIX further approval to the 2021 annual report disclosure IGEA Pharma N.V.
15-Jun-2022 PharmaSGP Holding SE successfully holds 2022 AGM PharmaSGP Holding SE
15-Jun-2022 SK pharmteco announces $35m investment in Phase 1 of new expansion plan for SK biotek Ireland’s Swords Campus SK pharmteco
15-Jun-2022 Aptamer Group signs deal with Flip Gene Therapeutics to support the development of inducible gene therapies Aptamer Group
15-Jun-2022 Keensight Capital invests in Cardiff-Based CatSci Ltd Keensight Capital
15-Jun-2022 BIOWIN, CETIC AND ESSENSCIA WALLONIE LAUNCH BIOMAN INITIATIVE TO ACCELERATE DIGITIZATION OF BIOPROCESSES IN WALLONIA BIOWIN
15-Jun-2022 Orion Acquires Inovet’s Animal Health Business Orion Corporation
15-Jun-2022 Aqilion resolves on issue in kind AQILION AB
15-Jun-2022 Almac Group records highest ever revenue, profit and employee numbers as $250 million global expansion plans announced Almac Group
15-Jun-2022 ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to GenScript ProBio B3C newswire
15-Jun-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1 2022 Financial Results and Highlights Operational Progress (news with additional features) Vivoryon Therapeutics N.V.
14-Jun-2022 MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210 MorphoSys AG
14-Jun-2022 ValenzaBio Engages ProBioGen For a Second Service Project ValenzaBio
14-Jun-2022 ValenzaBio Engages ProBioGen For a Second Service Project B3C newswire
14-Jun-2022 Bavarian Nordic Enters Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) in Response to Monkeypox Outbreak Bavarian Nordic
14-Jun-2022 TILT Biotherapeutics Announces over $10 Million Financing to Advance Oncology Immunotherapy Assets TILT Biotherapeutics
14-Jun-2022 Empagliflozin (Jardiance®) approved by MHRA as UK’s first effective treatment for symptomatic chronic heart failure regardless of ejection fraction MHRA